Aberrant FGFR signaling mediates resistance to CDK4/6 inhibitors in ER+ breast cancer
2019 · Nature Communications · 383 citations
https://doi.org/10.1038/s41467-019-09068-2
K
Kyung‐min Lee
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
129
Papers
3.5K
Citations
28
h-index
41
i10-index
Kyung‐min Lee is an academic researcher from University of Central Florida. The author has contributed to research in topics: Advanced Breast Cancer Therapies & Genomics and Chromatin Dynamics & Skin and Cellular Biology Research. The author has an h-index of 28, co-authored 110 publications.
ORCID: 0000-0001-8381-2423Papers by this author
worksThe role of IL-12 and TGF-β1 in the pathophysiology of major depressive disorder
2006 · International Immunopharmacology · 148 citations
https://doi.org/10.1016/j.intimp.2006.03.015
Co-occurring gain-of-function mutations in HER2 and HER3 modulate HER2/HER3 activation, oncogenesis, and HER2 inhibitor sensitivity
2021 · Cancer Cell · 94 citations
https://doi.org/10.1016/j.ccell.2021.06.001
Extracellular matrix protein 1 regulates cell proliferation and trastuzumab resistance through activation of epidermal growth factor signaling
2014 · Breast Cancer Research · 70 citations
https://doi.org/10.1186/s13058-014-0479-6
Cytokeratin19 induced by HER2/ERK binds and stabilizes HER2 on cell membranes
2014 · Cell Death and Differentiation · 59 citations
https://doi.org/10.1038/cdd.2014.155
Hyperactivation of TORC1 Drives Resistance to the Pan-HER Tyrosine Kinase Inhibitor Neratinib in HER2-Mutant Cancers
2020 · Cancer Cell · 49 citations
https://doi.org/10.1016/j.ccell.2019.12.013
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat